NASDAQ: TVGNTevogen Bio Holdings Inc Stock
$1.09+0.71 (+186.84%)
Updated Oct 14, 2024
TVGN Price
$1.09
Fair Value Price
-$0.01
Market Cap
$186.01M
52 Week Low
$0.26
52 Week High
$21.09
P/E
-0.45x
P/B
-24.37x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$57.09M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
-1.43
Operating Cash Flow
-$13M
Beta
0.31
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
TVGN Overview
Semper Paratus Acquisition Corporation is a "blank check" company formed to effect mergers, stock purchases, or similar combinations with one or more businesses. It targets the transportation, supply chain, and logistics sectors. Semper Paratus Acquisition was incorporated in 2021 and is headquartered in New York, NY.
Zen Score
–
Industry Average (23)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how TVGN scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
TVGN ($1.09) is overvalued by 11,210.36% relative to our estimate of its Fair Value price of -$0.01 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
TVGN ($1.09) is not significantly undervalued (11,210.36%) relative to our estimate of its Fair Value price of -$0.01 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
TVGN is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more TVGN due diligence checks available for Premium users.
Be the first to know about important TVGN news, forecast changes, insider trades & much more!
TVGN News
Valuation
TVGN fair value
Fair Value of TVGN stock based on Discounted Cash Flow (DCF)
Price
$1.09
Fair Value
-$0.01
Undervalued by
11,210.36%
TVGN ($1.09) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
TVGN ($1.09) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
TVGN is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
TVGN price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-0.45x
Industry
-124.07x
Market
27.44x
TVGN price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
-24.37x
Industry
6.12x
TVGN's financial health
Profit margin
Revenue
$0.0
Net Income
-$6.1M
Profit Margin
0%
TVGN's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
Assets to liabilities
Assets
$3.3M
Liabilities
$10.9M
Debt to equity
-1.43
TVGN's short-term liabilities ($10.61M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
TVGN's short-term assets ($2.45M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
TVGN's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
TVGN's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$3.0M
Investing
$0.0
Financing
$2.8M
TVGN's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
TVGN vs Biotech Stocks
Tevogen Bio Holdings Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.